Xencor reports promising kidney cancer drug results, plans late-stage trial
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Health & Medicine
'The Cat Is Out of the Bag': What We Heard This Week
(MedPage Today) -- "The cat is out of the bag." -- Adam Waickman, PhD, of SUNY Upstate Medical University in Syracuse, New York, discussing the large dengue outbreaks in Florida and warning of further…
New vaccine slashes chance of melanoma patients’ tumors returning, study shows
Personalized Moderna and Merck vaccine, called intismeran, was made with same Nobel Prize-winning mRNA technology behind COVID-19 vaccines
Trio of IgA Nephropathy Drugs Proves Mettle in Interim Analyses
(MedPage Today) -- DENVER -- Significant proteinuria reductions were reported in phase III interim analyses assessing two investigational IgA nephropathy agents and a third that was recently granted…
Pink's San Diego cancer benefit raises $8.25m, taking series past $28m
Pink's concert at San Diego's Petco Park on May 15, 2026, raised $8.25 million for cancer research, drawing around 25,000 attendees, including cancer survivors.
U.S. measles cases more than double what they were last year as outbreak spreads
Pennsylvania is the worst hit state, with at least 1,338 cases of measles confirmed in 44 counties so far this year, according to the Pennsylvania Department of Health.
U.S. measles cases more than double what they were last year as outbreak spreads
Pennsylvania is the worst hit state, with at least 1,338 cases of measles confirmed in 44 counties so far this year, according to the Pennsylvania Department of Health.